IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice

The Journal of Immunology : Official Journal of the American Association of Immunologists
Shmuel J CohenGabriel Nussbaum

Abstract

MyD88 is an adaptor molecule that functions in the innate signaling induced by proinflammatory adjuvants that interact with TLRs. Mice lacking MyD88, for example, resist active experimental autoimmune encephalomyelitis (EAE) induced by immunization with an encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide in CFA. We reasoned that MyD88(-/-) mice, nevertheless, should be susceptible to EAE mediated by adoptive transfer of activated encephalitogenic T cell lines, which do not require adjuvant signaling for their effector functions. We now report, however, that mice lacking MyD88 also resist adoptive EAE mediated by an anti-MOG T cell line that is strongly encephalitogenic in wild-type (WT) mice. The transferred anti-MOG T cells proliferated, secreted INF-gamma, and migrated to the CNS in the MyD88(-/-) mice, as they did in WT mice, but inflammatory infiltrates did not progress and clinical EAE did not develop. The resistance of the MyD88(-/-) mice to adoptive EAE mediated by the otherwise encephalitogenic T cells was found to result from the secretion of IL-10 by recipient T cells of two different specificities: those specific for MOG and those responding to the T cell clone itself-both anticlonotypic and antierg...Continue Reading

References

May 1, 1993·International Immunology·A W LohseK H Meyer zum Büschenfelde
Apr 1, 1996·The Journal of Experimental Medicine·G S GilkesonD S Pisetsky
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·F J QuintanaI R Cohen
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A WenskyJ J Lafaille
Sep 8, 2001·Nature Immunology·M SchnareR Medzhitov
Jul 4, 2002·International Immunology·Tsuneyasu KaishoShizuo Akira
Jan 14, 2003·Annual Review of Immunology·Kiyoshi TakedaShizuo Akira
May 20, 2003·Scandinavian Journal of Immunology·B RubinE E Sercarz
Jun 7, 2003·Journal of Autoimmunity·Estelle BettelliVijay K Kuchroo
Oct 21, 2003·International Immunology·Catherine WeirB Thomas Bäckström
Jul 21, 2004·Journal of the Neurological Sciences·Howard L Weiner
Nov 24, 2004·Clinical & Developmental Immunology·Hélène Feillet, Jean-François Bach
Jan 20, 2005·The Journal of Experimental Medicine·Claire L LangrishDaniel J Cua
May 4, 2005·Pharmacology & Therapeutics·Jaime ImitolaSamia J Khoury
Jul 23, 2005·International Reviews of Immunology·Avishai Mimran, Irun R Cohen
Jul 23, 2005·International Reviews of Immunology·Vipin Kumar, Eli Sercarz
Oct 4, 2005·Journal of Neuroimmunology·Kandace K FlemingJanet G Marquis
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shao Bo SuRachel R Caspi
Dec 31, 2005·Arthritis and Rheumatism·Xiaobo Wu, Stanford L Peng
Jan 28, 2006·The Journal of Clinical Investigation·Marco PrinzBurkhard Becher
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yutaka KomiyamaYoichiro Iwakura
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Elise H TranRichard A Flavell
Oct 24, 2006·Journal of Neuroimmunology·Abigail C Buenafe, Dennis N Bourdette
May 1, 2007·Arthritis and Rheumatism·Atsushi SadanagaMine Harada
Jul 25, 2007·The Journal of Experimental Medicine·Hsin-Jung WuDiane Mathis
Nov 10, 2007·Proceedings of the National Academy of Sciences of the United States of America·Daniel H D GrayDiane Mathis
Jan 19, 2008·European Journal of Immunology·Monica MartaAnna Lobell
Mar 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vicky LampropoulouSimon Fillatreau
Jul 16, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yutaro KumagaiShizuo Akira
Dec 25, 2008·PloS One·Francisco J QuintanaIrun R Cohen

❮ Previous
Next ❯

Citations

Feb 15, 2018·Proceedings of the National Academy of Sciences of the United States of America·Michael D KornbergPaul M Kim
Jan 27, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Siobhan Ni Choileain, Anne L Astier
May 17, 2014·Seminars in Immunopathology·Markus Krumbholz, Edgar Meinl
Oct 17, 2017·Nature Reviews. Immunology·Jean-François Bach
Mar 19, 2014·Cell Biochemistry and Biophysics·Weijiang WuGuozhen Hui
Oct 9, 2019·Immunopharmacology and Immunotoxicology·Seyedeh Masoomeh NoorbakhshAbbas Mirshafiey
Mar 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Avijit RayBonnie N Dittel
May 14, 2020·Human Vaccines & Immunotherapeutics·Orli Even-OrGabriel Nussbaum
Sep 3, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amber BartlettRobert A Barrington
Aug 17, 2010·International Immunopharmacology·Thomas M Petro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.